| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Keith Bley | Q125054991 |
| P2093 | author name string | P Anand | |
| P2860 | cites work | TRP channels and pain | Q83830678 |
| Microneurographic findings of relevance to pain in patients with erythromelalgia and patients with diabetic neuropathy | Q83949996 | ||
| Analgesic therapy in postherpetic neuralgia: a quantitative systematic review | Q21144723 | ||
| Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents | Q21146964 | ||
| Topical capsaicin for chronic neuropathic pain in adults | Q24240399 | ||
| Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain | Q24803051 | ||
| Microneurographic single-unit recordings to assess receptive properties of afferent human C-fibers | Q28246859 | ||
| The concept of neurogenic inflammation | Q28270661 | ||
| Vanilloid (Capsaicin) receptors and mechanisms | Q29617371 | ||
| Roles of capsaicin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. | Q30704153 | ||
| Expression of capsaicin receptor immunoreactivity in human peripheral nervous system and in painful neuropathies | Q33255110 | ||
| Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts | Q33293409 | ||
| Human keratinocytes are vanilloid resistant | Q33375740 | ||
| The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers | Q33546873 | ||
| Effects of the neurotrophic factor artemin on sensory afferent development and sensitivity | Q33585155 | ||
| Capsaicin induces degeneration of cutaneous autonomic nerve fibers | Q33742339 | ||
| Nerve growth factor and keratinocytes: a role in psoriasis | Q33849908 | ||
| NK1 (substance P) receptor antagonists--why are they not analgesic in humans? | Q33953249 | ||
| Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death | Q34001869 | ||
| Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain | Q34097542 | ||
| Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: a systematic review | Q34155583 | ||
| Postherpetic neuralgia: irritable nociceptors and deafferentation | Q34483000 | ||
| Neuropathic pain: redefinition and a grading system for clinical and research purposes | Q34713765 | ||
| Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin-sensitive cutaneous neurons. | Q53617813 | ||
| Final Report on the Safety Assessment of Capsicum Annuum Extract, Capsicum Annuum Fruit Extract, Capsicum Annuum Resin, Capsicum Annuum Fruit Powder, Capsicum Frutescens Fruit, Capsicum Frutescens Fruit Extract, Capsicum Frutescens Resin, and Capsaic | Q56093618 | ||
| Transient Receptor Potential Vanilloid Receptor Subtype 1 in Painful Bladder Syndrome and its Correlation With Pain | Q60731291 | ||
| Vanilloid receptor 1 immunoreactivity in inflamed human bowel | Q60731295 | ||
| Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome | Q60774817 | ||
| Increased intraepithelial innervation in women with vulvar vestibulitis syndrome | Q60774822 | ||
| Nerve fibre proliferation in interstitial cystitis | Q61614704 | ||
| Therapeutic studies on vulvar vestibulitis | Q67923877 | ||
| Capsaicin and its analogs inhibit the activity of NADH-coenzyme Q oxidoreductase of the mitochondrial respiratory chain | Q69189528 | ||
| The role of endogenous nerve growth factor in human diabetic neuropathy | Q71101919 | ||
| Idiopathic vulvodynia. Clinical evaluation of the pain threshold with acetic acid solutions | Q71871120 | ||
| Capsaicin-induced neurotoxicity in cultured dorsal root ganglion neurons: involvement of calcium-activated proteases | Q71899054 | ||
| Mechanism of inhibitory action of capsaicin on particulate axoplasmic transport in sensory neurons in culture | Q72086756 | ||
| Preventative effect of repeated nasal applications of capsaicin in cluster headache | Q72137018 | ||
| Inhibition of Axon Reflex Vasodilatation by Topically Applied Capsaicin | Q72634202 | ||
| Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers | Q73764922 | ||
| Uninjured C-fiber nociceptors develop spontaneous activity and alpha-adrenergic sensitivity following L6 spinal nerve ligation in monkey | Q74482520 | ||
| Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems | Q74534991 | ||
| Quantitative analysis of epidermal innervation in Fabry disease | Q77360442 | ||
| Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function | Q77458793 | ||
| Mechanisms of neuropathic pain | Q79173262 | ||
| Topical treatment of chronic low back pain with a capsicum plaster | Q79213613 | ||
| Nociception and TRP channels | Q79540571 | ||
| Impaired reinnervation in HIV infection following experimental denervation | Q80167210 | ||
| NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor | Q80382886 | ||
| Neuronal markers in allergic rhinitis: expression and correlation with sensory testing | Q80712410 | ||
| Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy) | Q82329571 | ||
| Determinants of epidermal nerve fiber density in normal individuals | Q82759217 | ||
| Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy | Q34785640 | ||
| Beyond neurons: evidence that immune and glial cells contribute to pathological pain states | Q34882677 | ||
| Topical therapy for osteoarthritis: clinical and pharmacologic perspectives | Q34971645 | ||
| Neurotrophic factors and their receptors in human sensory neuropathies | Q35618389 | ||
| Opportunities afforded by the study of unmyelinated nerves in skin and other organs | Q35788249 | ||
| Intranasal medications for the treatment of migraine and cluster headache | Q35843543 | ||
| Capsaicin for the treatment of vulvar vestibulitis | Q36131975 | ||
| Epidermal transient receptor potential vanilloid 1 in idiopathic small nerve fibre disease, diabetic neuropathy and healthy human subjects. | Q36237923 | ||
| Assessment of cutaneous sensory and autonomic axon reflexes in rheumatoid arthritis | Q36705051 | ||
| Quantitation of epidermal nerves in diabetic neuropathy | Q36825566 | ||
| Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain | Q36930795 | ||
| The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor | Q37023861 | ||
| The role of P2X₇ in pain and inflammation | Q37135501 | ||
| Transient receptor potential vanilloid subtype 1 channel mediated neuropeptide secretion and depressor effects: role of endoplasmic reticulum associated Ca2+ release receptors in rat dorsal root ganglion neurons | Q37160064 | ||
| Vulvodynia & pelvic pain? Think interstitial cystitis | Q37309062 | ||
| Current perspectives in vulvodynia. | Q37544852 | ||
| The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. | Q37629063 | ||
| Topical capsaicin. The fire of a 'hot' medicine is reignited | Q37743506 | ||
| Calcitonin gene-related peptide receptor antagonists for migraine | Q37756158 | ||
| Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain | Q37788207 | ||
| A "cute" desensitization of TRPV1. | Q37798852 | ||
| NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study | Q39312497 | ||
| The potential role of nerve growth factor (NGF) in painful neuromas and the mechanism of pain relief by their relocation to muscle | Q39346943 | ||
| Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction | Q39446855 | ||
| Treatment of intractable pain with topical large-dose capsaicin: preliminary report | Q39450327 | ||
| Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up | Q39504269 | ||
| TRPV1 shows dynamic ionic selectivity during agonist stimulation. | Q39994761 | ||
| Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes | Q40131858 | ||
| Capsaicin-induced depletion of substance P from primary sensory neurones | Q40164536 | ||
| TRPV1 at nerve endings regulates growth cone morphology and movement through cytoskeleton reorganization | Q40173261 | ||
| Glial cell-line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors. | Q40304242 | ||
| Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy | Q40667434 | ||
| Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency | Q40672234 | ||
| TRPV3 is a temperature-sensitive vanilloid receptor-like protein. | Q40723123 | ||
| Capsaicin-induced depolarisation of mitochondria in dorsal root ganglion neurons is enhanced by vanilloid receptors | Q40811651 | ||
| Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? | Q40982024 | ||
| Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. | Q42051248 | ||
| Increased NGF mRNA expression in denervated rat skin. | Q42512072 | ||
| Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score | Q42514396 | ||
| p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia | Q42526677 | ||
| The endoplasmic reticulum of dorsal root ganglion neurons contains functional TRPV1 channels | Q42661952 | ||
| Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain | Q43032039 | ||
| Natural history of cutaneous innervation following herpes zoster | Q43067287 | ||
| A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers | Q43094995 | ||
| Capsicum pain plaster in chronic non-specific low back pain | Q43838908 | ||
| The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy | Q44013935 | ||
| The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles | Q44038120 | ||
| Small fiber neuropathy is associated with the metabolic syndrome | Q44207440 | ||
| Repeated intranasal capsaicin applications to treat chronic migraine | Q44452962 | ||
| Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor | Q44483450 | ||
| Genotoxicity studies with pure trans-capsaicin. | Q44714424 | ||
| Increased vanilloid receptor VR1 innervation in vulvodynia | Q44778793 | ||
| The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy | Q44884912 | ||
| Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients | Q44903849 | ||
| Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. | Q45022108 | ||
| Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch | Q45056095 | ||
| Symptoms of Notalgia Paresthetica May Be Explained by Increased Dermal Innervation | Q45356904 | ||
| Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: high abundance and sensitivity in rectum and distal colon. | Q45982096 | ||
| Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. | Q45983561 | ||
| Pharmacokinetic and the effect of capsaicin in Capsicum frutescens on decreasing plasma glucose level. | Q46101053 | ||
| Cutaneous innervation density in the allodynic form of postherpetic neuralgia | Q46232843 | ||
| Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative? | Q46388325 | ||
| Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy | Q46562554 | ||
| In vitro hepatic and skin metabolism of capsaicin | Q46819105 | ||
| A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache | Q47635748 | ||
| Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain | Q48260903 | ||
| A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia | Q50440477 | ||
| Sensitisation of visceral afferents by nerve growth factor in the adult rat. | Q50537945 | ||
| Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. | Q50687545 | ||
| Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. | Q51282145 | ||
| Nerve growth factor signaling regulates motility and docking of axonal mitochondria. | Q51642532 | ||
| Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes. | Q53579259 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pain | Q81938 |
| analgesic | Q173235 | ||
| capsaicin | Q273169 | ||
| P304 | page(s) | 490-502 | |
| P577 | publication date | 2011-08-17 | |
| 2011-10-01 | |||
| P1433 | published in | British Journal of Anaesthesia | Q72466 |
| P1476 | title | Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch | |
| P478 | volume | 107 |
| Q39236443 | 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial |
| Q55044771 | 8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain. |
| Q92452018 | A Comprehensive Algorithm for Management of Neuropathic Pain |
| Q64082432 | A Country in Crisis: Opioid Sparing Solutions for Acute Pain Management |
| Q36217637 | A Mechanism-Based Approach to the Management of Osteoarthritis Pain |
| Q34301601 | A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial |
| Q26859032 | A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin |
| Q44735809 | A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia |
| Q42430667 | A randomized clinical trial of efficacy and safety of the topical clonidine and capsaicin in the treatment of painful diabetic neuropathy. |
| Q34655786 | A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic pain |
| Q55271301 | Acute effect of different concentrations of cayenne pepper cataplasm on sensory-motor functions and serum levels of inflammation-related biomarkers in healthy subjects. |
| Q36358428 | Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety) |
| Q38815838 | An overview of treatment approaches for chronic pain management |
| Q39162260 | Analgesic effect of topical oral capsaicin gel in burning mouth syndrome. |
| Q43067863 | Animal Toxins Providing Insights into TRPV1 Activation Mechanism. |
| Q36083250 | Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat. |
| Q34900858 | Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients |
| Q47131623 | Aural stimulation with capsaicin ointment improved swallowing function in elderly patients with dysphagia: a randomized, placebo-controlled, double-blind, comparative study |
| Q57754855 | Back-to-Back Screen-Printed Electroanalytical Sensors: Extending the Potential Applications of the Simplistic Design |
| Q46393535 | Ca2+ and calpain mediate capsaicin-induced ablation of axonal terminals expressing transient receptor potential vanilloid 1. |
| Q38669012 | Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain |
| Q39198311 | Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain |
| Q38198093 | Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world' clinical experience |
| Q36213567 | Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. |
| Q41057630 | Capsaicin 8% patch treatment for amputation stump and phantom limb pain: a clinical and functional MRI study |
| Q36536768 | Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain |
| Q47145945 | Capsaicin Enhances Glutamatergic Synaptic Transmission to Neonatal Rat Hypoglossal Motor Neurons via a TRPV1-Independent Mechanism. |
| Q26744369 | Capsaicin, Nociception and Pain |
| Q38221260 | Capsaicin-based therapies for pain control. |
| Q48192651 | Capsaicin-sensitive C- and A-fibre nociceptors control long-term potentiation-like pain amplification in humans |
| Q26745591 | Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses |
| Q47162516 | Capsaicin: Friend or Foe in Skin Cancer and Other Related Malignancies? |
| Q28660764 | Capsaicinoids in the treatment of neuropathic pain: a review |
| Q48534200 | Consensus recommendations for managing osteoarthritic pain with topical NSAIDs in Asia-Pacific |
| Q52565486 | Control of mechanical pain hypersensitivity in mice through ligand-targeted photoablation of TrkB-positive sensory neurons. |
| Q93127228 | Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls |
| Q33630847 | Current Understanding of Antiobesity Property of Capsaicin |
| Q37988158 | Deconstructing the neuropathic pain phenotype to reveal neural mechanisms |
| Q41993425 | Dependence of Nociceptive Detection Thresholds on Physiological Parameters and Capsaicin-Induced Neuroplasticity: A Computational Study |
| Q61806418 | Development of A New Delivery System Based on Drug-Loadable Electrospun Nanofibers for Psoriasis Treatment |
| Q98946364 | Development of a database of capsaicinoid contents in foods commonly consumed in Korea |
| Q92152793 | Diallel Analysis of Chilli Pepper (Capsicum annuum L.) Genotypes for Morphological and Fruit Biochemical Traits |
| Q92084348 | Diverse TRPV1 responses to cannabinoids |
| Q99583080 | Effect of 158 herbal remedies on human TRPV1 and the two-pore domain potassium channels KCNK2, 3 and 9 |
| Q83974334 | Effect of surgical and chemical sensory denervation on non-neural expression of the transient receptor potential vanilloid 1 (TRPV1) receptors in the rat |
| Q33588849 | Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study |
| Q34344341 | Effects of aural stimulation with capsaicin ointment on swallowing function in elderly patients with non-obstructive dysphagia |
| Q50502880 | Effects of capsaicin on testis ghrelin expression in mice. |
| Q90717006 | Efficacy and Safety of Diclofenac + Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study |
| Q48353623 | Ephedra Herb extract activates/desensitizes transient receptor potential vanilloid 1 and reduces capsaicin-induced pain |
| Q35576844 | Experimental evidence for alleviating nociceptive hypersensitivity by single application of capsaicin |
| Q89477374 | Fruits |
| Q90450609 | Functional and histological improvements of small nerve neuropathy after high-concentration capsaicin patch application: A case study |
| Q90388269 | Granulocyte-macrophage colony-stimulating factor receptor expression in clinical pain disorder tissues and role in neuronal sensitization |
| Q26741831 | Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other Diseases |
| Q41616309 | High-concentration capsaicin patch (qutenza) - a new step in treatment of neuropathic pain. |
| Q91781323 | Human Dorsal Root Ganglia |
| Q38317178 | Improving acute pain management in emergency medicine |
| Q46828841 | Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis |
| Q89928375 | Injection Techniques for Common Chronic Pain Conditions of the Foot: A Comprehensive Review |
| Q92830114 | Interleukin-31-mediated photoablation of pruritogenic epidermal neurons reduces itch-associated behaviours in mice |
| Q93377427 | Intra-articular treatment options for knee osteoarthritis |
| Q37734810 | Ion channels and migraine |
| Q37042583 | Is physician supervision of the capsaicin 8% patch administration procedure really necessary? An opinion from health care professionals |
| Q47371201 | Local Resiniferatoxin Induces Long-Lasting Analgesia in a Rat Model of Full Thickness Thermal Injury. |
| Q42736007 | Localized neuropathic pain: an expert consensus on local treatments |
| Q47977560 | MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis. |
| Q50072130 | Management of chronic neuropathic pain with single and compounded topical analgesics |
| Q59137615 | Managing Chronic Pain in the Elderly: An Overview of the Recent Therapeutic Advancements |
| Q34807873 | Mitochondrial fission augments capsaicin-induced axonal degeneration |
| Q26745795 | Multimodal management of dental pain with focus on alternative medicine: A novel herbal dental gel |
| Q36123798 | NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy |
| Q47652702 | Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential |
| Q36067194 | Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint |
| Q92178088 | Optimization of Rheological Behaviour and Skin Penetration of Thermogelling Emulsions with Enhanced Substantivity for Potential Application in Treatment of Chronic Skin Diseases |
| Q30442178 | Orofacial pain management: current perspectives |
| Q28245972 | Pachyonychia congenita cornered: report on the 11th Annual International Pachyonychia Congenita Consortium Meeting |
| Q54960570 | Pain in cancer survivors. |
| Q38823502 | Pain transduction: a pharmacologic perspective |
| Q49503498 | Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice |
| Q91840196 | Painful and Painless Diabetic Neuropathies: What Is the Difference? |
| Q91822729 | Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice |
| Q89739032 | Perineural application of resiniferatoxin on uninjured L3 and L4 nerves completely alleviates thermal and mechanical hypersensitivity following L5 nerve injury in rats |
| Q34384692 | Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment |
| Q35905866 | Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groups |
| Q22252962 | Pharmacological treatment for pain in Guillain-Barré syndrome |
| Q24186580 | Pharmacological treatment for pain in Guillain-Barré syndrome |
| Q39191235 | Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain. |
| Q28079910 | Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability |
| Q38349089 | Progress in the treatment of small fiber peripheral neuropathy |
| Q92476541 | Randomized, Double-Blind, Placebo-Controlled Trial of Intraarticular Trans-Capsaicin for Pain Associated With Osteoarthritis of the Knee |
| Q91906354 | Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification |
| Q88690684 | Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions |
| Q31133826 | Relative efficacy of topical non-steroidal anti-inflammatory drugs and topical capsaicin in osteoarthritis: protocol for an individual patient data meta-analysis |
| Q35846608 | Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations |
| Q37162636 | Responsiveness of electrical nociceptive detection thresholds to capsaicin (8 %)-induced changes in nociceptive processing |
| Q36037155 | Role of capsaicin-sensitive nerves and tachykinins in mast cell tryptase-induced inflammation of murine knees |
| Q35961756 | Short lasting transient effects of a capsaicin 8% patch on nociceptor activation in humans. |
| Q89889487 | Single components of botanicals and nature-identical compounds as a non-antibiotic strategy to ameliorate health status and improve performance in poultry and pigs |
| Q48309913 | Single high-concentration capsaicin application prevents c-Fos expression in spinothalamic and postsynaptic dorsal column neurons after surgical incision |
| Q38335767 | Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and Applications |
| Q38960281 | Spices: Potential Therapeutics for Alzheimer's Disease |
| Q47591159 | Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain |
| Q48301223 | Synthesis and biological evaluation of [¹¹C]SB366791: a new PET-radioligand for in vivo imaging of the TRPV1 receptor. |
| Q26745816 | TRP ion channels in thermosensation, thermoregulation and metabolism |
| Q47146568 | TRPA1 and TRPV1 are required for lidocaine-evoked calcium influx and neuropeptide release but not cytotoxicity in mouse sensory neurons |
| Q49357566 | TRPA1-dependent reversible opening of tight junction by natural compounds with an α,β-unsaturated moiety and capsaicin |
| Q37148698 | TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception |
| Q26738621 | TRPV1: A Target for Rational Drug Design |
| Q39290208 | Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain |
| Q37350660 | The Role of Capsaicin-induced Acute Inactivation of C-fibers on Tactile Learning in Rat. |
| Q64108951 | The Role of Toxins in the Pursuit for Novel Analgesics |
| Q50232049 | The anti-inflammatory effect of diclofenac is considerably augmented by topical capsaicinoids-containing patch in carrageenan-induced paw oedema of rat. |
| Q92734824 | The capsaicin receptor TRPV1 is the first line defense protecting from acute non damaging heat: a translational approach |
| Q55343198 | The detection of capsaicin and dihydrocapsaicin in horse serum following long-term local administration. |
| Q37509898 | The effect of capsaicin on expression patterns of CGRP in trigeminal ganglion and trigeminal nucleus caudalis following experimental tooth movement in rats |
| Q59797962 | The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials |
| Q94547392 | The role of Piper chaba Hunt. and its pure compound, piperine, on TRPV1 activation and adjuvant effect |
| Q88913284 | The time course of brief and prolonged topical 8% capsaicin-induced desensitization in healthy volunteers evaluated by quantitative sensory testing and vasomotor imaging |
| Q38460172 | Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain |
| Q34511501 | Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study |
| Q39167455 | Topical Treatments for Localized Neuropathic Pain |
| Q36369936 | Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews. |
| Q38265422 | Topical analgesics for neuropathic pain in the elderly: current and future prospects |
| Q34376548 | Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development |
| Q24200709 | Topical capsaicin (high concentration) for chronic neuropathic pain in adults |
| Q34549233 | Topical capsaicin (high concentration) for chronic neuropathic pain in adults. |
| Q24200378 | Topical capsaicin (low concentration) for chronic neuropathic pain in adults |
| Q36291861 | Topical capsaicin for neuropathic pain #255 |
| Q38551448 | Topical treatment in pain medicine: from ancient remedies to modern usage |
| Q33697613 | Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review. |
| Q38583019 | Transdermal drug delivery: feasibility for treatment of superficial bone stress fractures. |
| Q38166804 | Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics. |
| Q38082796 | Transient receptor potential vanilloid 1 as a therapeutic target in analgesia |
| Q39181518 | Treatment of Neuropathic Pain |
| Q34805660 | Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary? |
| Q38823614 | Treatment of painful radiculopathies with capsaicin 8% cutaneous patch |
| Q42282310 | Trench Foot or Non-Freezing Cold Injury As a Painful Vaso-Neuropathy: Clinical and Skin Biopsy Assessments |
| Q36240286 | Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report. |
| Q28073741 | Use of Capsaicin to Treat Pain: Mechanistic and Therapeutic Considerations |
| Q90478616 | Zerumbone Modulates α2A-Adrenergic, TRPV1, and NMDA NR2B Receptors Plasticity in CCI-Induced Neuropathic Pain In Vivo and LPS-Induced SH-SY5Y Neuroblastoma In Vitro Models |
| Q85643273 | [Pronounced symptom deterioration in complex regional pain syndrome type II after isolated application of a highly concentrated capsaicin patch. A case report] |
Search more.